Mucosal vaccines have been a source of a lot of excitement in recent years. How are they different from your usual flu vaccine, and are they more effective?
Category: pharma & healthcare
Massachusetts Legislation To Curb Use Of Step Therapy – A Health Insurers’ Drug Cost Containment Tool- Fails To Move Forward
This summer, the Massachusetts House and Senate passed legislation aimed at curbing the use of step therapy. Yet the House and Senate couldn’t agree on an item in the bill. Despite failing to go through, patient advocates are still hopeful a bill can g…
Progress In The Search For Broadly Neutralizing Monoclonal Antibodies VII
The P2G3 antibody is the latest in a long line of potential SARS-CoV-2 monoclonal antibody treatments to neutralize a broad range of viral variants.
What Will Happen To Coverage Of Covid-19 Tests, Vaccines, And Treatments Once The Government Is No Longer The Predominant Purchaser?
The federal government will stop being the predominant purchaser of Covid-19 vaccines, treatments, and tests at some point this fall. White House Covid-19 Response Team coordinator Dr Ashish Jha said his “hope is that in 2023 you’re going to see commer…
Covid-19 Infection Increases Risk And Excess Burden Of Cardiovascular Disease
A study demonstrates that infection with Covid-19 impacts the risk of cardiovascular events up to 12 months post-infection, regardless of age, race, sex, and other cardiovascular risk factors.
Long Covid Is Keeping Millions Of People Out Of Work
A new Brookings report finds that Long Covid is keeping as many as 4 million people out of work.
If Covid-19 Public Health Emergency Ends, Millions Of Americans Could Lose Healthcare Coverage
The Biden Administration may allow the Covid-19 Public Health Emergency to expire October 13th. This portends the loss of healthcare coverage for potentially millions of people.
Hopeful New Entry In The Race For A Universal Covid Vaccine
A Swedish research team suggests their vaccine candidate may protect against many SARS-Cov-2 variants.
Progress In The Search For Broadly Neutralizing Monoclonal Antibodies VI
These latest broadly neutralizing monoclonal antibodies not only overcome major Omicron strains, but many other related coronaviruses as well.
What “Negotiating” With Medicare Means For Drug Makers: A Mixture Of Price Controls And Actual Negotiations
The bill imposes a number of controls, such as minimum discounts off of non-federal AMP, as well as a framework for how to define “fair” prices and how the negotiating process will determine prices based on factors such as R&D costs, unmet need, therap…
